VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FATE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FATEFate Therapeutics, Inc.
$3.02$352M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFATEQuarterly Cash Flow

Fate Therapeutics, Inc. (FATE) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Fate Therapeutics, Inc. (FATE) quarterly cash flow statement — complete operating, investing & financing history

FATE Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations-30.82M-23.31M-24.37M-24.59M-33.81M-27.8M-29.42M-32.31M-33.35M-36.64M-38.27M-28.49M-28.86M-75.39M-55.05M-53.16M-64.61M-70.29M-33.38M-32.11M
Operating CF Margin %-2372.75%-1702.99%-1400%-1289.3%-2075.45%-1494.57%-957.03%-477.05%-1732.47%-2185.98%-1968.78%-3053.91%-48.93%-169.96%-367.45%-286.59%-350.89%-411.82%-234.62%-239.38%
Operating CF Growth %8.83%16.13%17.15%23.89%-1.38%24.12%23.13%-13.38%-15.56%51.4%30.47%46.4%55.33%-7.25%-64.93%-65.57%-138.46%-240.17%-8.6%-182.66%
Net Income-31.21M0-32.25M-34.07M-37.62M-52.15M-47.68M-38.43M-48M-44.12M-45.17M-52.76M-18.88M-56.36M-83.56M-76.11M-65.69M-68.62M-43.31M-55.13M
Depreciation & Amortization2.15M-3.79M3.23M3.28M3.33M4.81M4.61M4.72M4.82M4.88M4.74M4.47M4.19M4.84M3.19M2.96M2.76M2.21M1.52M1.17M
Stock-Based Compensation3.93M04.86M7.15M7.38M9.12M11.77M9.63M10.98M010.1M010.98M019.47M20.54M19.33M14.59M13.54M13.25M
Deferred Taxes00000000000000000000
Other Non-Cash Items280K-20.58M-716K-1.02M-1.53M12.33M-1.24M-4.44M-1.76M2.79M-5.13M9.76M-37.3M8.68M-4.27M603K-9.89M-5.61M-14.4M9.07M
Working Capital Changes-5.96M1.05M504K73K-5.37M-1.91M3.13M-3.79M614K-189K-2.82M10.04M12.15M-32.55M10.12M-1.16M-11.13M-12.87M9.28M-460K
Change in Receivables212K-233K713K1.01M1.13M588K-2.48M-190K968K-288K1.3M10.67M24.98M-28.26M2.9M724K-5.17M-1.36M2.99M-3.36M
Change in Inventory00000000000000000000
Change in Payables-5.77M865K00001.87M00-1.89M0-4.37M-20.39M3.39M10.28M0-3.49M000
Cash from Investing23.59M27.63M21.27M19.59M42.67M22.82M25.46M-53.37M17.31M45.35M24.8M33.17M9.34M53.11M80.38M40.29M-7.03M71.28M77.96M-1.37M
Capital Expenditures-239K-1.19M-2.2M-1.36M-1.2M-98K-495K-51K-86K-181K-565K-2.2M-3.21M-6.68M-8.68M-10.13M-10.08M-18.37M-14.73M-13.62M
CapEx % of Revenue18.4%87.07%126.54%71.42%73.42%5.27%16.1%0.75%4.47%10.8%29.06%235.69%5.44%15.05%57.91%54.61%54.76%107.62%103.59%101.54%
Acquisitions0-122K000000000000000000
Investments--------------------
Other Investing0359K3K122K0000000000000000
Cash from Financing01.69M2.48M1.32M03.13M01.27M95.49M-180K058K207K1.52M1.49M3.41M2.8M3.42M7.94M3.72M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)0000000-662K75.19M-180K058K207K1.52M1.49M02.8M-31K-20.68M1K
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing01.69M2.48M1.32M03.13M01.94M20.3M0000003.41M03.45M28.62M3.72M
Net Change in Cash-7.24M6.01M-627K-3.67M8.86M-1.85M992K-84.41M79.45M8.54M-13.47M4.78M-19.31M-20.76M26.82M-9.47M-68.84M4.4M52.53M-29.76M
Free Cash Flow-31.06M-24.51M-26.58M-25.95M-35.01M-27.9M-29.91M-32.36M-33.44M-36.82M-38.84M-30.69M-32.07M-82.07M-63.72M-63.29M-74.7M-88.66M-48.11M-45.73M
FCF Margin %-2391.15%-1790.07%-1526.54%-1360.72%-2148.86%-1499.84%-973.13%-477.81%-1736.94%-2196.78%-1997.84%-3289.6%-54.37%-185.02%-425.36%-341.19%-405.65%-519.43%-338.21%-340.93%
FCF Growth %11.27%12.16%11.16%19.8%-4.69%24.23%22.98%-5.42%-4.27%55.14%39.05%51.5%57.07%7.44%-32.45%-38.41%-140.36%-286.56%-51.83%-219.68%
FCF per Share-0.26-0.21-0.22-0.22-0.30-0.24-0.25-0.28-0.33-0.37-0.39-0.31-0.33-0.84-0.66-0.65-0.78-0.93-0.50-0.48
FCF Conversion (FCF/Net Income)0.99x0.72x0.76x0.72x0.90x0.53x0.62x0.84x0.69x0.83x0.85x0.54x1.53x1.34x0.66x0.70x0.98x1.02x0.77x0.58x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000